Inventor
RASMUSSEN LARS KYHN
DK43 patents
⚠️ This page may combine multiple inventors who share the name “RASMUSSEN LARS KYHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
36 patentsUS10034861B2Jul 31, 2018
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS13 citations92
US11026924B2Jun 8, 2021
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS4 citations84
US11026923B2Jun 8, 2021
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS4 citations84
US10806718B2Oct 20, 2020
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS7 citations84
US10689379B2Jun 23, 2020
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
H LUNDBECK AS6 citations84
US10618913B2Apr 14, 2020
Macrocycles as PDE1 inhibitors
H LUNDBECK AS7 citations84
US10512632B2Dec 24, 2019
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors
H LUNDBECK AS9 citations84
US10011606B2Jul 3, 2018
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS8 citations84
US10351561B2Jul 16, 2019
Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors
H LUNDBECK AS12 citations83
US9850249B2Dec 26, 2017
PDE9 inhibitors with imidazo triazinone backbone
H LUNDBECK AS6 citations83
US9593105B2Mar 14, 2017
Cyclic amines
H LUNDBECK AS5 citations83
US9533992B2Jan 3, 2017
PDE9 inhibitors with imidazo triazinone backbone
H LUNDBECK AS10 citations83
US9434733B2Sep 6, 2016
PDE9 inhibitors with imidazo triazinone backbone
H LUNDBECK AS7 citations83
US9415055B2Aug 16, 2016
Cyclic amines
H LUNDBECK AS4 citations83
US9643970B2May 9, 2017
Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors
H LUNDBECK AS8 citations82
US11491140B2Nov 8, 2022
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10858362B2Dec 8, 2020
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10766893B2Sep 8, 2020
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS6 citations73
US10633382B2Apr 28, 2020
Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10538525B2Jan 21, 2020
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
H LUNDBECK AS5 citations73
US10150771B2Dec 11, 2018
Triazolopyrazinones as PDE1 inhibitors
H LUNDBECK AS7 citations73
US9718832B2Aug 1, 2017
Hexahydrofuropyrroles as PDE1 inhibitors
H LUNDBECK AS2 citations73
US9701665B2Jul 11, 2017
Quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS3 citations73
US9993477B2Jun 12, 2018
Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors
H LUNDBECK AS3 citations72
US11535611B2Dec 27, 2022
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
H LUNDBECK AS1 citations62
US11472810B2Oct 18, 2022
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS0 citations62
US11104680B2Aug 31, 2021
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
H LUNDBECK AS1 citations62
US10912773B2Feb 9, 2021
Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations62
US10905688B2Feb 2, 2021
Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations62
US9861639B2Jan 9, 2018
Cyclic amines
H LUNDBECK AS1 citations62
US11851425B2Dec 26, 2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines
H LUNDBECK AS0 citations52
US11634416B2Apr 25, 2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines
H LUNDBECK AS0 citations52
US10526319B2Jan 7, 2020
Halogenated quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS0 citations52
US10030007B2Jul 24, 2018
Quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS0 citations52
US10005764B2Jun 26, 2018
Halogenated quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS1 citations52
US9649308B2May 16, 2017
Benzamide-containing compounds and their use in the treatment of pain
H LUNDBECK AS1 citations51